From: Usage of compromised lung volume in monitoring steroid therapy on severe COVID-19
Outcome | Unadjusted | Adjusted | ||||
---|---|---|---|---|---|---|
Changes in quantitative CT parameters (%) | Coefficient | 95% CI | P value | Coefficient | 95% CI | P value |
Changes in CLa |  − 7.44 |  − 10.01 to − 4.87 |  < 0.01 |  − 3.27 |  − 5.86 to − 0.68 | 0.01 |
Changes in NNLb |  − 1.75 |  − 3.01 to − 0.48 |  < 0.01 |  − 0.68 |  − 1.61 to 0.24 | 0.15 |
Changes in PALc |  − 5.71 |  − 7.66 to − 3.77 |  < 0.01 |  − 1.44 |  − 3.46 to 0.57 | 0.16 |
Changes in NALd | 7.46 | 4.03 to 10.88 |  < 0.01 | 6.17 | 3.51 to 8.83 |  < 0.01 |
Changes in HIe | 0.06 |  − 2.81 to 2.92 | 0.97 |  − 1.86 |  − 4.73 to 1.01 | 0.20 |